Lamotrigin Ct

Lamotrigine, the active ingredient in Lamotrigin Ct, is an anticonvulsant presented as an oral tablet for oral administration. It belongs to the antiepileptic and mood‑stabilizing therapeutic classes and is used to control partial and generalized tonic‑clonic seizures as well as to maintain stability in bipolar disorder for adult patients.

GNH USA supplies Lamotrigin Ct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent product quality, regulatory adherence, and reliable logistics for global healthcare providers.

Lamotrigine is used in the treatment of seizure disorders and mood‑stabilization in bipolar disorder. - Epilepsy (partial seizures): Reduces frequency and severity of focal onset seizures. - Epilepsy (generalized tonic‑clonic seizures): Helps prevent recurrence of generalized convulsive seizures. - Bipolar disorder (maintenance therapy): Maintains mood stability and reduces risk of depressive and manic episodes.

Lamotrigine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Skin rash: mild erythema or itching, usually self‑limited. - Headache: transient mild to moderate pain. - Dizziness: light‑headedness or imbalance, often positional. - Nausea: mild stomach upset, may improve with food. - Fatigue: general tiredness, common during dose adjustments.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe blistering skin reaction, requires immediate stop. - Toxic epidermal necrolysis: extensive skin loss with systemic signs, medical emergency. - Aseptic meningitis: fever, neck stiffness, headache without infection. - Hematologic abnormalities: pancytopenia, aplastic anemia, or agranulocytosis. - Hepatic injury: elevated liver enzymes or hepatitis. - Rash with fever: possible early indicator of severe skin reaction.

When prescribing lamotrigine, clinicians should consider several precautionary measures to minimize risk and ensure safe use. - Initiate therapy at low dose: start small and titrate slowly to lower rash risk. - Monitor skin reactions: stop immediately if any rash appears, especially severe. - Assess hepatic function: exercise caution in liver impairment. - Review concomitant meds: enzyme inducers may reduce lamotrigine levels. - Pregnancy counseling: discuss risks and benefits with women of childbearing potential. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture.

Lamotrigine's plasma concentration can be altered by several co‑administered drugs, requiring attention to interaction potential.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising toxicity risk; monitor for skin reactions. - Carbamazepine: significantly reduces lamotrigine levels, may diminish efficacy; consider dose increase.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine concentrations, possibly needing dose adjustment; review effectiveness. - Phenobarbital or phenytoin: enzyme inducers that decrease lamotrigine exposure; may require higher dose. - Serotonergic agents: combined use may increase risk of serotonin syndrome, monitor symptoms such as agitation or hyperreflexia.